All Square Wealth Management LLC Nektar Therapeutics Transaction History
All Square Wealth Management LLC
- $169 Million
- Q1 2024
A detailed history of All Square Wealth Management LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, All Square Wealth Management LLC holds 277 shares of NKTR stock, worth $324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
277
Previous 277
-0.0%
Holding current value
$324
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NKTR
# of Institutions
128Shares Held
111MCall Options Held
150KPut Options Held
4K-
Deep Track Capital, LP Greenwich, CT18.4MShares$21.5 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$14.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA7.57MShares$8.86 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA6.97MShares$8.15 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.88MShares$6.88 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $219M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...